You are here

Home

DiaCarta, Inc.

Company Information
Address
2600 Hilltop Dr Bldg B Flr 3
Richmond, CA 94806-1971
United States
Information

UEI: LY4NEL8B8FK9

# of Employees: 16
Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: No

Woman Owned: No

Award Charts




Award Listing

  • Record 1 TO 6

  1. Discovery of new small molecule TLR4 agonists for the treatment of allergic rhinitis

    Amount: $41,693.00

    This pilot study is aimed at judging the efficacy of the lead compound with a clinically relevant allergenThe relevant allergen chosen for this study is the house dust mite Dermatophagoides pteronyssi ...

    SBIRPhase II2019Department of Health and Human Services National Institutes of Health

  2. Topic 345: RadTox- Measuring Radiation Toxicity using Circulating DNA

    Amount: $1,999,984.00

    The QuantiDNA RadTox System is a unique, patented technology that measures tissue damage shortly following injury using cell-free DNA from a drop of blood. Premised on murine and primate studies showi ...

    SBIRPhase II2018Department of Health and Human Services National Institutes of Health

  3. IGF OT IGF PREDICTIVE BIOMARKERS OF ADVERSE REACTIONS TO RADIATION TREATMENT POP

    Amount: $299,698.00

    In different individuals exposed to radiation radiation will cause variable levels of rapid combined tissue death cell apoptosis and necrosis leading to toxicity This acute tissue loss correlates wi ...

    SBIRPhase I2016Department of Health and Human Services National Institutes of Health

  4. FGF-P to treat post-irradiation GI syndrome

    Amount: $594,739.00

    DESCRIPTION (provided by applicant): For victims of gastrointestinal (GI) radiation exposure and concomitant GI syndrome, DiaCarta's fibroblast growth factor-peptide (FGF-P) is a product that wi ...

    SBIRPhase I2012Department of Health and Human Services National Institutes of Health

  5. Novel Methods for Rapid Detection of Infection Agents and the Severity of Cellular Damage

    Amount: $749,291.00

    Early detection of virulent infectious pathogens is critical to blocking the devastating epidemic spread of the pathogen and the potential harm this could have on our armed forces and general populati ...

    STTRPhase II2010Department of Defense Defense Advanced Research Projects Agency

  6. Novel Methods for Rapid Detection of Infection Agents and the Severity of Cellular Damage

    Amount: $99,000.00

    The development of early detection methods to aid in the identification of virulent infectious pathogens is of strategic importance so that exposed warfighters and other individuals can be treated ear ...

    STTRPhase I2008Department of Defense Defense Advanced Research Projects Agency
US Flag An Official Website of the United States Government